Effects of pioglitazone and high-fat diet on ceramide metabolism in rat skeletal muscles

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 10, 2006, Pages 101-114

  Zendzian Piotrowska, Małgorzata ^a   Baranowski, M ^a   Zabielski, P ^a   Gorski J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Ceramidase; Ceramide; High fat diet; Pioglitazone; PPAR; Skeletal muscle; Sphingomyelinase

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CERAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; SPHINGANINE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DEACYLATION; DRUG MECHANISM; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; GASTROCNEMIUS MUSCLE; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; MALE; MUSCLE LEVEL; NONHUMAN; RAT; RECEPTOR UPREGULATION; SKELETAL MUSCLE; SOLEUS MUSCLE;

AMIDOHYDROLASES; ANIMALS; CERAMIDES; DIETARY FATS; FATTY ACIDS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MAGNESIUM; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; THIAZOLIDINEDIONES;

EID: 34047276087     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Plutzky J. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms. Curr Atheroscler Rep 2000; 2: 327-335.
2. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 2000; 106: 847-856.
3. Ohanian J, Ohanian V. Sphingolipids in mammalian cell signalling. Cell Mol Life Sci 2001; 58: 2053-2068.
4. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2005; 45: 42-72.
5. Dobrzyn A, Gorski J. Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise. Am J Physiol Endocrinol Metab 2002; 282: E277-E285.
6. Straczkowski M, Kowalska I, Nikolajuk A, et al. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 2004; 53: 1215-1221.
7. Dobrzyn A, Gorski J. Effect of acute exercise on the content of free sphinganine and sphingosine in different skeletal muscle types of the rat. Horm Metab Res 2002; 34: 523-529.
8. Helge JW, Dobrzyn A, Saltin B, Gorski J. Exercise and training effects on ceramide metabolism in human skeletal muscle. Exp Physiol 2004; 89: 119-127.
9. Merrill AH Jr, Nixon DW, Williams RD. Activities of serine palmitoyltransferase (3-ketosphinganine synthase) in microsomes from different rat tissues. J Lipid Res 1985; 26: 617-622.
10. Dobrzyn A, Zendzian-Piotrowska M, Gorski J. Effect of endurance training on the sphingomyelin-signalling pathway activity in the skeletal muscles of the rat. J Physiol Pharmacol 2004; 55: 305-313.
11. Turinsky J, O.Sullivan DM, Bayly BP. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem 1990; 265: 16880-16885.
12. Gorska M, Dobrzyn A, Zendzian-Piotrowska M, Gorski J. Effect of streptozotocin-diabetes on the functioning of the sphingomyelin-signalling pathway in skeletal muscles of the rat. Horm Metab Res 2004; 36: 14-21.
13. Adams JM 2nd, Pratipanawatr T, Berria R, et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004; 53: 25-31.
14. Gilde AJ, Van Bilsen M. Peroxisome proliferator-activated receptors (PPARs): regulators of gene expression in heart and skeletal muscle. Acta Physiol Scand 2003; 178: 425-434.
15. Stumvoll M. Thiazolidinediones - some recent developments. Expert Opin Investig Drugs 2003; 12: 1179-1187.
16. Yonemitsu S, Nishimura H, Shintani M, et al. Troglitazone induces GLUT4 translocation in L6 myotubes. Diabetes 2001; 50: 1093-1101.
17. Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats. Metabolism 2001; 50: 1294-1300.
18. Lessard SJ, Lo Giudice SL, Lau W, et al. Rosiglitazone enhances glucose tolerance by mechanisms other than reduction of fatty acid accumulation within skeletal muscle. Endocrinology 2004; 145: 5665-5670.
19. Planavila A, Alegret M, Sanchez RM, Rodriguez-Calvo R, Laguna JC, Vazquez-Carrera M. Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice. Biochem Pharmacol 2005; 69: 1195-1204.
20. Pascoe WS, Storlien LH. Inducement by fat feeding of basal hyperglycemia in rats with abnormal beta-cell function. Model for study of etiology and pathogenesis of NIDDM. Diabetes 1990; 39: 226-233.
21. Yano M, Kishida E, Muneyuki Y, Masuzawa Y. Quantitative analysis of ceramide molecular species by high performance liquid chromatography. J Lipid Res 1998; 39: 2091-2098.
22. Mahadevappa VG, Holub BJ. Chromatographic analysis of phosphoinositides and their breakdown products in activated blood platelets/neutrophils. In Chromatography of Lipids in Biomedical Research and Clinical Diagnosis, A Kuksis (ed). Amsterdam, Elsevier, 1987, pp. 225-265.
23. Roemen TH, van der Vusse GJ. Application of silica gel column chromatography in the assessment of non-esterified fatty acids and phosphoglycerides in myocardial tissue. J Chromatogr 1985; 344: 304-308.
24. Nawrocki A, Gorski J. Effect of plasma free fatty acid concentration on the content and composition of the free fatty acid fraction in rat skeletal muscles. Horm Metab Res 2004; 36: 601-606.
25. Min JK, Yoo HS, Lee EY, Lee WJ, Lee YM. Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Anal Biochem 2002; 303: 167-175.
26. Liu B, Hannun YA. Sphingomyelinase assay using radiolabeled substrate. Methods Enzymol 2000; 311: 164-167.
27. Nikolova-Karakashian M, Merrill AH Jr. Ceramidases. Methods Enzymol 2000; 311: 194-201.
28. Yang L, Mutanen M, Cheng Y, Duan RD. Effects of fat, beef and fiber in diets on activities of sphingomyelinase, ceramidase and caspase-3 in rat colonic mucosa. Med Princ Pract 2002; 11: 150-156.
29. Geelen MJ, Beynen AC. Consumption of olive oil has opposite effects on plasma total cholesterol and sphingomyelin concentrations in rats. Br J Nutr 2000; 83: 541-547.
30. Todd MK, Watt MJ, Le J, Hevener AL, Turcotte LP. Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance. Am J Physiol Endocrinol Metab 2006 (in press).
31. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002; 51: 2005-2011.
32. Yu C, Chen Y, Cline GW, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002; 277: 50230-50236.
33. Lee JS, Pinnamaneni SK, Eo SJ, et al. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 2006; 100: 1467-1474.
34. Cabrero A, Jove M, Planavila A, Merlos M, Laguna JC, Vazquez-Carrera M. Down-regulation of acyl-CoA oxidase gene expression in heart of troglitazone-treated mice through a mechanism involving chicken ovalbumin upstream promoter transcription factor II. Mol Pharmacol 2003; 64: 764-772.
35. Carley AN, Semeniuk LM, Shimoni Y, et al. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function. Am J Physiol Endocrinol Metab 2004; 286: E449-E455.
36. Ye JM, Dzamko N, Cleasby ME, et al. Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin. Diabetologia 2004; 47: 1306-1313.
37. Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000; 97: 1784-1789.
38. Clore JN, Li L, Rizzo WB. Effects of fructose and troglitazone on phospholipid fatty acid composition in rat skeletal muscle. Lipids 2000; 35: 1281-1287.
39. Hallakou S, Foufelle F, Doare L, Kergoat M, Ferre P. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation. Diabetologia 1998; 41: 963-968.
40. Kawamura T, Yoshida K, Sugawara A, et al. Regulation of skeletal muscle peroxisome proliferator-activated receptor gamma expression by exercise and angiotensin-converting enzyme inhibition in fructose-fed hypertensive rats. Hypertens Res 2004; 27: 61-70.